ea0029oc12.1 | Obesity Clinical | ICEECE2012
Fanelli F.
, Mezzullo M.
, Belluomo I.
, Di Lallo V.
, Colavita M.
, Baccini M.
, Casadio E.
, Ibarra Gasparini D.
, Vicennati V.
, Pasquali R.
, Pagotto U.
Obesity is characterized by an increase of endocannabinoid circulating levels as anandamide (AEA) and 2-arachidonoyl-glycerol (2AG). Whether these lipids represent a biomarker of dysmetabolism or merely reflect the fat mass spill-over is still unclear. After generating rigorous, gender specific, plasma reference intervals by 2D-liquid chromatography-tandem mass spectrometry, we defined the 97.5thcentile of endocannabinoid distribution in the normal population as the cut-off ab...